Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis

探索局部应用托法替尼治疗儿童全秃

阅读:2

Abstract

Alopecia totalis (AT) is an autoimmune condition and severe form of alopecia areata characterized by complete scalp hair loss, often posing treatment challenges, especially in pediatric patients. This case report presents a 7-year-old boy with a 2-year history of alopecia, who developed AT. The patient initially showed limited response to a combination of Wysolone (prednisolone) and methotrexate. The introduction of topical tofacitinib along with mometasone resulted in significant hair regrowth and improvement in hair density over a 4-month period. This case highlights the potential of topical Janus kinase inhibitors as a promising treatment for the pediatric patient with AT.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。